These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31533822)

  • 41. Cancer biomarker discovery: the entropic hallmark.
    Berretta R; Moscato P
    PLoS One; 2010 Aug; 5(8):e12262. PubMed ID: 20805891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microrna profiling analysis of differences between the melanoma of young adults and older adults.
    Jukic DM; Rao UN; Kelly L; Skaf JS; Drogowski LM; Kirkwood JM; Panelli MC
    J Transl Med; 2010 Mar; 8():27. PubMed ID: 20302635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?
    Margue C; Reinsbach S; Philippidou D; Beaume N; Walters C; Schneider JG; Nashan D; Behrmann I; Kreis S
    Oncotarget; 2015 May; 6(14):12110-27. PubMed ID: 25883223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcriptome stability profiling using 5'-bromouridine IP chase (BRIC-seq) identifies novel and functional microRNA targets in human melanoma cells.
    Joshi P; Seki T; Kitamura S; Bergano A; Lee B; Perera RJ
    RNA Biol; 2019 Oct; 16(10):1355-1363. PubMed ID: 31179855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A four-gene expression-based signature predicts the clinical outcome of melanoma.
    Sun L; Li P; Ren H; Liu G; Sun L
    J BUON; 2019; 24(5):2161-2167. PubMed ID: 31786890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Independent Principal Component Analysis for biologically meaningful dimension reduction of large biological data sets.
    Yao F; Coquery J; Lê Cao KA
    BMC Bioinformatics; 2012 Feb; 13():24. PubMed ID: 22305354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identifying cancer-related microRNAs based on gene expression data.
    Zhao XM; Liu KQ; Zhu G; He F; Duval B; Richer JM; Huang DS; Jiang CJ; Hao JK; Chen L
    Bioinformatics; 2015 Apr; 31(8):1226-34. PubMed ID: 25505085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-throughput miRNA profiling of human melanoma blood samples.
    Leidinger P; Keller A; Borries A; Reichrath J; Rass K; Jager SU; Lenhof HP; Meese E
    BMC Cancer; 2010 Jun; 10():262. PubMed ID: 20529253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exploring matrix factorization techniques for significant genes identification of Alzheimer's disease microarray gene expression data.
    Kong W; Mou X; Hu X
    BMC Bioinformatics; 2011; 12 Suppl 5(Suppl 5):S7. PubMed ID: 21989140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma.
    Xin X; Zhang Y; Ling F; Wang L; Sheng X; Qin L; Zhao X
    Exp Eye Res; 2019 Mar; 180():242-249. PubMed ID: 30615885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of miRNA-mRNA regulatory modules by exploring collective group relationships.
    Masud Karim SM; Liu L; Le TD; Li J
    BMC Genomics; 2016 Jan; 17 Suppl 1(Suppl 1):7. PubMed ID: 26817421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
    Bai Y; Ding L; Baker S; Bai JM; Rath E; Jiang F; Wu J; Jiang H; Stuart G
    BMC Bioinformatics; 2016 Oct; 17(Suppl 13):336. PubMed ID: 27766936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MMpred: functional miRNA--mRNA interaction analyses by miRNA expression prediction.
    Stempor PA; Cauchi M; Wilson P
    BMC Genomics; 2012 Nov; 13():620. PubMed ID: 23151045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miRLAB: An R Based Dry Lab for Exploring miRNA-mRNA Regulatory Relationships.
    Le TD; Zhang J; Liu L; Liu H; Li J
    PLoS One; 2015; 10(12):e0145386. PubMed ID: 26716983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploring combinations of dimensionality reduction, transfer learning, and regularization methods for predicting binary phenotypes with transcriptomic data.
    Oshternian SR; Loipfinger S; Bhattacharya A; Fehrmann RSN
    BMC Bioinformatics; 2024 Apr; 25(1):167. PubMed ID: 38671342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
    Gong Q; Wan Q; Li A; Yu Y; Ding X; Lin L; Qi X; Hu L
    Aging (Albany NY); 2020 Oct; 12(20):20254-20267. PubMed ID: 33100273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs.
    Hämäläinen M; Teppo HR; Skarp S; Haapasaari KM; Porvari K; Vuopala K; Kietzmann T; Karihtala P
    Oxid Med Cell Longev; 2019; 2019():2647068. PubMed ID: 31687076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive transcriptome profiling of Taiwanese colorectal cancer implicates an ethnic basis for pathogenesis.
    Wu SM; Tsai WS; Chiang SF; Lai YH; Ma CP; Wang JH; Lin J; Lu PS; Yang CY; Tan BC; Liu H
    Sci Rep; 2020 Mar; 10(1):4526. PubMed ID: 32161294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer.
    Ochoa AE; Choi W; Su X; Siefker-Radtke A; Czerniak B; Dinney C; McConkey DJ
    Oncotarget; 2016 Dec; 7(49):80164-80174. PubMed ID: 27845906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.